
Aden Mendoza
@adenmendoza_
PGY-0 @Dukeneurosurg | @DukeMedSchool '25 | @ucsdbiosciences MS '18, BS '17
ID: 1917258668141051904
29-04-2025 16:44:32
0 Tweet
16 Followers
147 Following

Congratulations to UCSF School of Medicine Mulki Mehari for publishing science.org/doi/epdf/10.11…. Despite the goal of maximizing enrollment of brain cancer patients in clinical trials, many studies fail to meet recruitment targets.


New in Science Advances, Mulki Mehari, Annette Molinaro, PhD, Shawn Hervey-Jumper, and their colleagues present a new AI-based clinical trial enrollment tool that provides recommendations for personalized for each patient’s circumstances: science.org/doi/10.1126/sc… UCSF Helen Diller Family Comprehensive Cancer Ctr


In glioma, T cell immunotherapies are limited by the quantity of available T cells. Kirit Singh Peter Fecci Mustafa Khasraw (find me in BlueSky) & team address this challenge in preclinical models by peripheral injection of autologous T cells after pre-treatment with IL-7. Full report
